Improving Medication Use. Advancing Patient Care.

APhA is the leading advocate for the pharmacy profession

Offering quality education, practice tools, and resources to help you reach your full potential as a patient care provider

Learn more

News View all news

April 18, 2019

New guide shows how penicillin allergy testing can be done in different settings

Penicillin allergy skin testing (PAST) is rapidly becoming an effective, long-term antimicrobial stewardship tool to optimize antimicrobial prescribing in various practice settings. In February 2019, a group of pharmacists from various institutions across the United States published a practical guide to implementing a PAST program. “Pharmacists are well positioned to offer PAST services given their existing duties as part of the health care team and expertise and training with drug allergy issues,” the authors wrote.

April 18, 2019

Appalachian Regional Prescription Opioid Strike Force takedown results in charges against 60

Federal officials announced Wednesday enforcement actions against 60 individuals, including 53 medical professionals, for their alleged participation in the illegal prescribing and distributing of opioids and other dangerous narcotics.

April 17, 2019

FDA takes steps to protect consumers from unlawful ingredients in dietary supplements

As part of its ongoing efforts to protect consumers from potentially unlawful dietary supplements, FDA said Tuesday it is launching a new tool to quickly alert the public to when it becomes aware of ingredients that appear to be unlawfully marketed in dietary supplements.

April 16, 2019

90 new cases of measles reported in U.S. as outbreak continues record pace

The number of confirmed measles cases in the United States increased sharply in the past week, with 90 new cases as of April 11. CDC said Monday there have been 555 cases of the highly infectious disease recorded so far in 2019.

April 15, 2019

FDA approves first targeted therapy for metastatic bladder cancer

FDA on Friday granted accelerated approval to erdafitinib (Balversa—Janssen Pharmaceutical) for the treatment of adults with locally advanced or metastatic bladder cancer that has an FGFR3 or FGFR2 genetic alteration and that has progressed during or following prior platinum-containing chemotherapy.

Students

Let APhA help you through your pharmacy training and beyond.

Learn More

New Practitioners

Your career starts here. Get the tools you need to kick-start your career.

Learn More

Pharmacists

Reach your full potential as a pharmacist with these helpful practice tools and resources.

Learn More

Pharmacy Technicians

Media/Press

Not a member? See What APhA can do for you

CEO Blog

by Thomas E. Menighan

View all CEO blog posts

April 9, 2019

What’s the right treatment plan for pharmacist workforce supply…

Imbalances between workforce supply and demand are notoriously difficult to resolve. Market corrections can take decades to work themselves out, and leaving the market to self-correct doesn’t help…

Safety in the pharmacy: Continuing the dialogue

You may have noticed a resurgence recently of the online dialogue about the safety of pharmacists in the workplace, particularly after a pharmacist and technician were shot and wounded at their…

Press Releases

View all press releases

March 29, 2019

APhA2019: Moving Pharmacy Forward

The American Pharmacists Association (APhA) Annual Meeting & Exposition, APhA2019, held March 22–25, hosted almost 6,000 pharmacists and student pharmacists in Seattle. This year’s theme, Moving Pharmacy Forward, highlighted the pharmacist’s role in addressing public health concerns and promoted personal and professional well-being while continuing to prioritize patient care services.

March 11, 2019

APhA Partners with iForumRx.org on New Line of Ambulatory Care Recertification Tools

The American Pharmacists Association (APhA) announced a partnership with iForumRx.org, an interactive web-based community for ambulatory care pharmacy specialists, to produce a new line of recertification tools centered around podcasts, panel discussions, and polls.

Why APhA?

APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.